The regulatory file for L-serine, market by market
L-serine is bought as a food or supplement ingredient, so its regulatory file has to describe the material, the released lot and the destination market together. This page names the frameworks and the documents that belong in that file; it does not replace the buyer's regulatory review. The supplier's part is the specification, the batch certificate and the change-control record, and those should refer to the same version.
The specification covers the powder; the market file has to show the permitted route, the limits that apply and the label wording for the destination.
The four questions the file answers
The file has to answer four things: what the material is and which specification revision applies; which lot is being released and what its certificate says; which limits and labelling rules the finished product must meet; and what happens when the source, process or pack changes. The COA covers the lot, the TDS covers the specification and the SDS covers handling. The route question sits outside all three.
Add the allergen and GMO declarations, the origin file, the residual-solvent declaration and any customer-specific document. If a statement is missing, name the gap before the order rather than finding it at customs. Keep a list with version numbers; a folder of undated PDFs is not a file.
An amino acid supplied as food or a supplement ingredient does not automatically enter the food-additive route. Additive and supplement routes are separate, and the destination market's regulatory team decides which one covers the finished product.
European Union
The EU review starts with the material, the contaminant results and the label. Regulation (EC) No 178/2002 sets the general food-law framework; Directive 2002/46/EC covers food supplements; Regulation (EU) No 1169/2011 covers labelling; Regulation (EU) 2023/915 sets contaminant limits. Product-specific rules may also apply. The consolidated text in force at the time of sale is the reference.
Novel-food status is a separate question under Regulation (EU) 2015/2283. The buyer's regulatory team checks whether the ingredient and the intended use fall inside that framework for the destination member state and keeps the conclusion on file. Meeting a specification does not settle the route.
Great Britain and Northern Ireland are reviewed separately: GB uses the GB register and GB labelling, while Northern Ireland follows the EU framework. One shipment can require two different files.
United States
US review begins with the dietary ingredient or food substance and the use it is put to. A dietary supplement is governed by the Federal Food, Drug, and Cosmetic Act as amended by DSHEA, with the current good-manufacturing-practice rules in 21 CFR 111 and the supplement labelling rules. If the dietary-ingredient route requires a notification, the buyer's team confirms that the basis covers the ingredient and the finished product.
A conventional food use follows the food-additive or GRAS route instead, and the two are not interchangeable with the supplement route. The supplier documents the material; the buyer selects the route. Label and claim review are separate from the certificate.
Contaminant limits
The contaminant numbers have to be calculated for the finished product, because a drum result does not account for the daily dose or the other ingredients. The table is a starting point for a supplement file; the current destination text and the dose decide the final limit.
| Parameter | Ingredient specification | Finished-product reference | Evidence the file should hold |
|---|---|---|---|
| Lead (Pb) | ≤3 mg/kg | 3.0 mg/kg in the supplement (EU) | Lot result, method and the dose calculation |
| Cadmium (Cd) | ≤1 mg/kg | 1.0 mg/kg in the supplement (EU) | Lot result and any category exception |
| Mercury (Hg) | ≤0.1 mg/kg | 0.10 mg/kg in the supplement (EU) | Lot result and method |
| Arsenic (As) | ≤2 mg/kg | No harmonised EU limit; customer limit | The agreed limit and the method |
The arithmetic is the evidence. A lot at 3 mg/kg lead can still put the finished product over its limit when the dose is high or another ingredient contributes lead. Show the calculation. Also distinguish “below the limit” from “below the detection limit”, because they mean different things.
Claims and the label
A label has to state the material, its quantity and its source in the form the destination requires. For L-serine the L form belongs in the name because the enantiomer is part of the identity. Claim review is a separate exercise: the brand's reviewer confirms the wording is permitted for the product, its form and the destination.
EU health claims fall under Regulation (EC) No 1924/2006 and must be authorised for the effect claimed. In the US, a structure-function claim needs the required disclaimer and substantiation, while a disease claim is outside that route. This page makes no disease-related claim. A certificate is not a claim approval, and a claim does not alter the specification.
Documents that belong in the file
- Specification, with version, CAS number and L form.
- Batch COA with methods, limits and results, including rotation.
- Technical data sheet and safety data sheet.
- Allergen, GMO, origin and residual-solvent declarations.
- Irradiation and BSE/TSE statements where required.
- Change-control record for source, process, mesh and pack.
The documents must agree. If the specification names L-serine, the certificate says only “serine” and the label says neither, the file has a gap even when each page looks complete. Keep version numbers and lot codes so a later question can be answered from the file.
Checklist before ordering
- The specification revision, CAS number and L form are identified.
- COA, TDS, SDS and the allergen, GMO, origin and residual-solvent declarations are present.
- The contaminant figures are expressed at the finished-product dose.
- The label and any claim have been reviewed for the destination.
- Source, process, mesh and pack are under change control.
- Quotation, specification and certificate use the same version.
The catalog specification is on the L-serine product page. For the lot record, see the COA page; for the analytical case, see the identity page. The quality page sets out the release file, and the EU regulatory note gives the framework references. A related amino acid is handled on the glycine page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation